在人类中SARS-CoV-2脂质纳米粒子mRNA疫苗的血液分布

Stephen J Kent1,2, Shiyao Li3, Thakshila H Amarasena1

  • 1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria 3000, Australia.

ACS nano
|September 19, 2024
PubMed
概括

在mRNA疫苗中对聚乙烯甘醇 (PEG) 的抗体可能会影响其循环和清除. 较高的PEG抗体水平与血液中疫苗成分的增加以及由单细胞减少的细胞化相关,影响免疫性.